Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000327291 | SCV000225770 | pathogenic | not provided | 2015-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000327291 | SCV000329453 | pathogenic | not provided | 2021-12-27 | criteria provided, single submitter | clinical testing | Normal stop codon changed to a Leucine codon, leading to the addition of 14 amino acids at the C-terminus; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18494745, 20132240, 28321846, 21850189, 25555363, 22204637, 16098226, 6330922, 18494744, 16199712, 22361317, 28698011, 18241071, 10477494, 11309364, 26661695, 12552561, 27431685, 29618921, 29367200, 32360764, 33594928, 27535533, 34101622, 33726816, 32467297) |
Fulgent Genetics, |
RCV000762838 | SCV000893197 | pathogenic | Aniridia 1; Foveal hypoplasia 1; Coloboma of optic nerve; Autosomal dominant keratitis; Isolated optic nerve hypoplasia; Irido-corneo-trabecular dysgenesis; 11p partial monosomy syndrome; Congenital ocular coloboma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000805010 | SCV000944952 | pathogenic | Aniridia 1; Irido-corneo-trabecular dysgenesis | 2024-10-22 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the PAX6 mRNA. It is expected to extend the length of the PAX6 protein by 14 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This protein extension has been observed in individual(s) with aniridia (PMID: 11309364, 12552561, 27431685, 28321846, 29618921). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this PAX6 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 10,718 individuals referred to our laboratory for PAX6 testing. This variant is also known as c.1290 A>T and X437L. ClinVar contains an entry for this variant (Variation ID: 3474). For these reasons, this variant has been classified as Pathogenic. |
Wessex Regional Genetics Laboratory, |
RCV000003642 | SCV001055829 | pathogenic | Aniridia 1 | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000327291 | SCV001247619 | pathogenic | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | PAX6: PP1:Strong, PM2, PM4, PS4:Moderate, PM6:Supporting, PP4 |
Clinical Genetics and Genomics, |
RCV000327291 | SCV001450012 | likely pathogenic | not provided | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Sing |
RCV005234778 | SCV005881521 | likely pathogenic | Foveal hypoplasia 1 | 2025-02-05 | criteria provided, single submitter | clinical testing | Prevalence in affected patients is greater compared to the general populace (PS4). The variant extends the protein length past the stop codon (PM4). Variant is not found in gnomAD exomes or genomes (PM2). There is cosegregation with disease phenotypes in multiple families across multiple studies (PP1_str, PMID: 21850189;25555363;22361317;18241071;26661695;12552561;27431685;29618921;29367200;33594928) |
OMIM | RCV000003642 | SCV000023805 | pathogenic | Aniridia 1 | 2003-02-01 | no assertion criteria provided | literature only | |
Laboratory of Genetic Epidemiology, |
RCV000003642 | SCV000584165 | pathogenic | Aniridia 1 | no assertion criteria provided | research | ||
Clinical Genetics and Genomics, |
RCV000785745 | SCV000924312 | likely pathogenic | Hypertelorism; Visual impairment; Nystagmus | 2018-03-29 | flagged submission | clinical testing |